Copd Newswire (Page 9)

Comprehensive Real-Time News Feed for Copd. (Page 9)

Results 161 - 180 of 223 in Copd

  1. Miner due Black Lung benefits despite smoking history: CourtRead the original story

    Aug 8, 2014 | Business Insurance

    ... of his lungs, according to court filings. Mr. Sterling, who had used an oxygen tank since 1995, was diagnosed with COPD after he was laid off. Mr. Sterling filed for benefits in October 2006 under the Black Lung Benefits Act. His claim was denied by ...

    Comment?

  2. Effectiveness of the Assessment of Burden of Chronic Obstructive...Read the original story

    Aug 6, 2014 | BioMed Central

    ... , Denise Schuiten , Gerard van Breukelen , Daniel Kotz and Onno CP van Schayck Chronic Obstructive Pulmonary Disease (COPD) is a growing worldwide problem that imposes a great burden on the daily life of patients. Since there is no cure, the goal of ...

    Comment?

  3. Bayonne Medical Center, CarePoint Health charge $9K to bandage man's fingerRead the original story w/Photo

    Aug 6, 2014 | Examiner.com

    ... -- part of a chain called CarePoint Healthcare -- charges the highest prices for several types of procedures, including COPD treatment, among the regional hospitals reviewed by HuffPost. Its price for that treatment runs four times the average in ...

    Comment?

  4. Actavis welcomes AZ in boosting its LAMA/LABARead the original story w/Photo

    Aug 6, 2014 | In-PharmaTechnologist.com

    ... was acquiring Barcelona, Spain-based drug delivery firm Almirall for $875m (a 650m) in order to enhance its asthma and COPD portfolio, whilst adding inhaler and particle technology technologies. Almirall was developing a fixed dose combination drug ...

    Comment?

  5. Aradigm to Host Analyst Meeting and Webcast on August 12 in New York CityRead the original story w/Photo

    Aug 6, 2014 | Business Wire

    ... of the Lung Volume Reduction program at the New York-Presbyterian Hospital. He chairs the board of directors of the COPD Foundation. His areas of expertise are in Pulmonary Disease including non-CF BE, COPD, Emphysema, Asthma, and Interstitial Lung ...

    Comment?

  6. AstraZeneca coughs up $875m for Almirall to support asthma/COPD pipelineRead the original story w/Photo

    Aug 4, 2014 | In-PharmaTechnologist.com

    The total price of the Barcelona, Spain-headquartered pharma firm could reach $1.22bn following development, launch, and sales-related milestones, but its respiratory assets will strengthen the Pharma Giant's inhaled asthma and COPD portfolio, adding to the inhaler and particle technology acquired in the $1.5bn Pearl Therapeutics transaction in ... (more)

    Comment?

  7. AstraZeneca agrees to strategic transaction with Almirall in respiratory diseaseRead the original story w/Photo

    Aug 2, 2014 | Big News Network.com

    ... transaction, AstraZeneca will own Almirall's entire cadre of lung treatments and delivery devices, led by on-the-market COPD drug Eklira. It will have rights for the development and commercialisation of Almirall's existing proprietary respiratory ...

    Comment?

  8. FDA Approves Striverdi Respimat (Olodaterol) to Treat COPDRead the original story

    Aug 1, 2014 | P&T Community

    ... Boehringer Ingelheim Pharmaceuticals) inhalation spray to treat patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema, who are experiencing airflow obstruction. COPD is a serious lung disease that ...

    Comment?

  9. Striverdi Respimat Approved to Treat COPDRead the original story

    Aug 1, 2014 | Kansas City InfoZine

    Striverdi Respimat can be used once daily over a long period of time. COPD is a serious lung disease that makes breathing difficult and worsens over time.

    Comment?

  10. COPD Drug, Striverdi Respimat, Receives FDA ApprovalRead the original story w/Photo

    Aug 1, 2014 | Medical Daily

    ... approved by the Food and Drug Administration (FDA) for once daily treatment of chronic obstructive pulmonary disease (COPD) afflicting millions of children and adults. The new long-term medication treats patients with COPD, including chronic ...

    Comment?

  11. NAPSR news: FDA approves Boehringer Ingelheim's Striverdi Respimat to treat COPDRead the original story

    Aug 1, 2014 | PR Log

    ... as they continuously expand on their respiratory product pipeline. to treat chronic obstructive pulmonary disease (COPD) which encompasses chronic bronchitis and/or emphysema that are experiencing airflow obstruction. The drug is administered in the ...

    Comment?

  12. FDA Approves New COPD TreatmentRead the original story

    Jul 31, 2014 | Journal Watch

    ... spray as a once-daily maintenance therapy for chronic obstructive pulmonary disease. In a trial of 3100 people with COPD, those who took the medication had improved lung function, compared with those who took placebo. Like other long-acting ...

    Comment?

  13. Striverdi Respimat found to help COPD sufferers breathe easierRead the original story w/Photo

    Jul 31, 2014 | Examiner.com

    In an effort to help patients with Chronic Obstructive Pulmonary Disease (better known as COPD ) breathe easier, the FDA has approved the use of Striverdi Respimat (olodaterol) inhalation spray to relax the muscles around the airways in the lungs ...

    Comment?

  14. Boehringer Ingelheim Ups The Ante In Treating Lung DisordersRead the original story w/Photo

    Jul 31, 2014 | BioResearch Online

    ... the company's position as a pioneer and leader in respiratory therapy, mainly in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. BI belongs to a small handful of pharmas, such as its fellow German company ...

    Comment?

  15. AstraZeneca will acquire Almirall's respiratory drug portfolioRead the original story

    Jul 31, 2014 | PR Log

    ... and commercial capabilities, we will strengthen our ability to address the entire spectrum of care in asthma and COPD. I very much look forward to welcoming the Almirall people to our company." Jorge Gallardo, President of Almirall added: "This ...

    Comment?

  16. Chronic obstructive pulmonary disease flare-ups: an interview with...Read the original story w/Photo

    Jul 30, 2014 | Medical News

    Dr. Han: During a flare-up, symptoms of a patient's COPD worsen significantly, and breathing becomes more difficult.

    Comment?

  17. AstraZeneca PLC Scoops Up Almirall Lung Drugs For Up To $2.1 BillionRead the original story

    Jul 30, 2014 | BioSpace

    Astrazeneca Agrees Strategic Transaction With Almirall In Respiratory Disease Business combination will provide boost to revenue as well as creating long-term value, strengthening AstraZeneca's respiratory franchise with a complementary pipeline and inhaled device capabilities in asthma and COPD AstraZeneca today announced that it has entered an ... (more)

    Comment?

  18. AstraZeneca to Acquire Almirall's Respiratory Disease BusinessRead the original story w/Photo

    Jul 30, 2014 | Pharmaceutical Processing

    ... and commercial capabilities, we will strengthen our ability to address the entire spectrum of care in asthma and COPD. I very much look forward to welcoming the Almirall people to our company." Jorge Gallardo, President of Almirall said: "This ...

    Comment?

  19. The Financial Costs Of COPD Estimated To Be $36...Read the original story w/Photo

    Jul 30, 2014 | RedOrbit

    Image Caption: COPD is one of the many chronic lower respiratory diseases which are currently the number three leading cause of death of Americans.

    Comment?

  20. Strategic Respiratory Transaction with AlmirallRead the original story

    Jul 29, 2014 | GlobeNewswire

    ASTRAZENECA AGREES STRATEGIC TRANSACTION WITH ALMIRALL IN RESPIRATORY DISEASE Business combination will provide boost to revenue as well as creating long-term value, strengthening AstraZeneca's respiratory franchise with a complementary pipeline and inhaled device capabilities in asthma and COPD AstraZeneca today announced that it has entered an ... (more)

    Comment?